Incidence of A-Fib Reduced With Vitamin D₃ Supplementation
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 14, 2023 -- For generally healthy older adults, vitamin D3 supplementation at 1,600 IU/day or 3,200 IU/day is associated with a reduction in the incidence of atrial fibrillation (AF) during five years of follow-up, according to a research letter published online June 10 in the American Heart Journal.
Jyrki K. Virtanen, Ph.D., from the University of Eastern Finland in Kuopio, and colleagues compared the effects of five-year vitamin D3 supplementation versus placebo on AF risk among generally healthy men (aged 60 years and older) and postmenopausal women (aged 65 years and older). A total of 2,495 participants were randomly assigned to receive 1,600 IU/day or 3,200 IU/day vitamin D3 or placebo (832, 833, and 830 participants, respectively).
The researchers found that 190 participants were diagnosed with AF during a mean follow-up of 4.1 years. The absolute incidence rate difference was 0.57 per 100 person-years between the 1,600 IU/day and placebo arms and 0.68 per 100 person-years between the 3,200 IU/day and placebo arms. The AF risk was 27 and 32 percent lower in the 1,600-IU/day and 3,200-IU/day arms, respectively, compared with the placebo arm. The risk was reduced by 30 percent in the combined vitamin D3 arms versus the placebo arm. When excluding participants diagnosed with AF during the first two years of follow-up, the risk reductions were larger.
"Our findings suggest possible benefit in AF prevention with high-dose vitamin D supplementation in an elderly population, despite the relatively high baseline 25(OH)D concentrations," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Three-Month Blanking Period After A-Fib Ablation Should Be Shortened, Researchers Say
MONDAY, April 22, 2024 -- The three-month blanking period (BP) after atrial fibrillation (AF) ablation, when recurrences are not thought to predict long-term outcome, is called...
2000-2010 to 2011-2022 Saw Increase in Lifetime Risk for A-Fib
FRIDAY, April 19, 2024 -- From 2000 to 2022, there was an increase in the lifetime risk for atrial fibrillation, according to a study published online April 17 in The...
Periodontitis May Modify Risk for Atrial Fibrillation
THURSDAY, April 11, 2024 -- Periodontitis is a risk factor for atrial fibrillation (AF), according to a study published online April 10 in the Journal of the American Heart...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.